Logos Global Management LP

Investment Portfolio & 13F Holdings Analysis

About

Type: FundHoldings: 39Value: $562.5MLatest: 2025Q1

Logos Global Management LP is an institutional investment manager that filed its latest Form 13F for 2025Q1, reporting 39 holdings worth $0.6 billion. Form 13F filings provide transparency into the equity holdings of institutional investment managers with over $100 million in assets under management. This page displays the most recent portfolio holdings, allowing investors to track position changes, new investments, and portfolio composition.

AI_NATIVE detailed information: This accession holds the following tickers:[
  "OCUL",
  "AKRO",
  "NUVL",
  "TRVI",
  "RVMD",
  "ANNX",
  "ATXS",
  "OLMA",
  "GPCR",
  "RAPP",
  "KROS",
  "ALLK",
  "JANX",
  "ARTV",
  "GERN",
  null,
  "SEPN",
  "UNCY",
  null,
  "ACRS",
  "IDYA",
  "TEVA",
  "RNA",
  null,
  "SLDB",
  "MLTX",
  "SLNO",
  "ETNB",
  "DYN",
  "GLYC",
  "CMPS",
  "ERAS",
  "ELVN",
  "DSGN",
  "XENE",
  "IMVT",
  "BNTX",
  "CRNX",
  "IRON"
]

Filing Details

13F-HR • 2025-03-31

SEC FilingSEC DataHachi Filing

Report Date: 2025-03-31
Filing Date: 2025-05-15
Total Holdings: 39
Total Value: 562541126
Accession Number: 0001172661-25-002012
Form Type: 13F-HR
CIK: logos-global-management-lp
Manager Name: Logos-Global-Management-Lp

Data Enrichment

92% identified

36 identified3 unidentified

Holdings

SEC FilingSEC DataHachi Filing

Manager:

39 positions • $562.5M total value

SEC FilingSEC DataHachi Filing

Manager:

Search and click to pin securities to the top

Page 1 of 2

Sort by:

IDEAYA Biosciences, Inc.

IDYA|45166A102

Shares:3.5M

Value:$57.3M

% of Portfolio:10.2% ($57.3M/$562.5M)

Revolution Medicines, Inc.

RVMD|76155X100

Shares:1.6M

Value:$56.6M

% of Portfolio:10.1% ($56.6M/$562.5M)

Akero Therapeutics, Inc.

AKRO|00973Y108

Shares:1.2M

Value:$48.6M

% of Portfolio:8.6% ($48.6M/$562.5M)

Janux Therapeutics, Inc.

JANX|47103J105

Shares:1.6M

Value:$44.5M

% of Portfolio:7.9% ($44.5M/$562.5M)

Nuvalent, Inc.

NUVL|670703107

Shares:500.0K

Value:$35.5M

% of Portfolio:6.3% ($35.5M/$562.5M)

TEVA PHARMACEUTICAL INDUSTRIES LTD

TEVA|881624209

Shares:1.7M

Value:$26.1M

% of Portfolio:4.6% ($26.1M/$562.5M)

Xenon Pharmaceuticals Inc.

XENE|98420N105

Shares:650.0K

Value:$21.8M

% of Portfolio:3.9% ($21.8M/$562.5M)

Keros Therapeutics, Inc.

KROS|492327101

Shares:2.0M

Value:$20.4M

% of Portfolio:3.6% ($20.4M/$562.5M)

Disc Medicine, Inc.

IRON|254604101

Shares:394.3K

Value:$19.6M

% of Portfolio:3.5% ($19.6M/$562.5M)

BioNTech SE

BNTX|09075V102

Shares:200.0K

Value:$18.2M

% of Portfolio:3.2% ($18.2M/$562.5M)

89bio, Inc.

ETNB|282559103

Shares:2.5M

Value:$18.2M

% of Portfolio:3.2% ($18.2M/$562.5M)

SOLENO THERAPEUTICS INC

SLNO|834203309

Shares:250.0K

Value:$17.9M

% of Portfolio:3.2% ($17.9M/$562.5M)

Erasca, Inc.

ERAS|29479A108

Shares:13.0M

Value:$17.8M

% of Portfolio:3.2% ($17.8M/$562.5M)

OCULAR THERAPEUTIX, INC

OCUL|67576A100

Shares:2.3M

Value:$16.9M

% of Portfolio:3.0% ($16.9M/$562.5M)

Design Therapeutics, Inc.

DSGN|25056L103

Shares:4.2M

Value:$16.3M

% of Portfolio:2.9% ($16.3M/$562.5M)

MoonLake Immunotherapeutics

MLTX|61559X104

Shares:350.0K

Value:$13.7M

% of Portfolio:2.4% ($13.7M/$562.5M)

GERON CORP

GERN|374163103

Shares:8.0M

Value:$12.7M

% of Portfolio:2.3% ($12.7M/$562.5M)

Olema Pharmaceuticals, Inc.

OLMA|68062P106

Shares:3.2M

Value:$12.1M

% of Portfolio:2.1% ($12.1M/$562.5M)

Crinetics Pharmaceuticals, Inc.

CRNX|22663K107

Shares:350.0K

Value:$11.7M

% of Portfolio:2.1% ($11.7M/$562.5M)

Avidity Biosciences, Inc.

RNA|05370A108

Shares:350.0K

Value:$10.3M

% of Portfolio:1.8% ($10.3M/$562.5M)

Instrument	Shares		Other Manager	Value	% of Portfolio
IDEAYA Biosciences, Inc.(IDYAcusip45166A102)	3.5M	QoQ +16.66% (-500.0K) YoY +133.33% (-2.0M)	All Managers (Combined)	$57.3M	10.2% ($57.3M/$562.5M)	QoQ -25.64% (-$19.8M) YoY -12.89% (-$8.5M)
Revolution Medicines, Inc.(RVMDcusip76155X100)	1.6M	QoQ +10.34% (-150.0K) YoY NEW(+1.6M)	All Managers (Combined)	$56.6M	10.1% ($56.6M/$562.5M)	QoQ -10.79% (-$6.8M) YoY NEW(+$56.6M)
Akero Therapeutics, Inc.(AKROcusip00973Y108)	1.2M	QoQ +50.00% (+400.0K) YoY +50.00% (+400.0K)	All Managers (Combined)	$48.6M	8.6% ($48.6M/$562.5M)	QoQ +118.26% (+$26.3M) YoY +140.38% (+$28.4M)
Janux Therapeutics, Inc.(JANXcusip47103J105)	1.6M	QoQ +32.00% (-400.0K) YoY +1000.00% (+1.5M)	All Managers (Combined)	$44.5M	7.9% ($44.5M/$562.5M)	QoQ -33.43% (-$22.4M) YoY +688.84% (+$38.9M)
Nuvalent, Inc.(NUVLcusip670703107)	500.0K	QoQ NEW(+500.0K) YoY NEW(+500.0K)	All Managers (Combined)	$35.5M	6.3% ($35.5M/$562.5M)	QoQ NEW(+$35.5M) YoY NEW(+$35.5M)
TEVA PHARMACEUTICAL INDUSTRIES LTD(TEVAcusip881624209)	1.7M	QoQ NEW(+1.7M) YoY NEW(+1.7M)	All Managers (Combined)	$26.1M	4.6% ($26.1M/$562.5M)	QoQ NEW(+$26.1M) YoY NEW(+$26.1M)
Xenon Pharmaceuticals Inc.(XENEcusip98420N105)	650.0K	QoQ NEW(+650.0K) YoY NEW(+650.0K)	All Managers (Combined)	$21.8M	3.9% ($21.8M/$562.5M)	QoQ NEW(+$21.8M) YoY NEW(+$21.8M)
Keros Therapeutics, Inc.(KROScusip492327101)	2.0M	QoQ NEW(+2.0M) YoY NEW(+2.0M)	All Managers (Combined)	$20.4M	3.6% ($20.4M/$562.5M)	QoQ NEW(+$20.4M) YoY NEW(+$20.4M)
Disc Medicine, Inc.(IRONcusip254604101)	394.3K	QoQ +97.17% (+194.3K) YoY NEW(+394.3K)	All Managers (Combined)	$19.6M	3.5% ($19.6M/$562.5M)	QoQ +54.37% (+$6.9M) YoY NEW(+$19.6M)
BioNTech SE(BNTXcusip09075V102)	200.0K	QoQ -33.33% (-100.0K) YoY NEW(+200.0K)	All Managers (Combined)	$18.2M	3.2% ($18.2M/$562.5M)	QoQ -46.72% (-$16.0M) YoY NEW(+$18.2M)
89bio, Inc.(ETNBcusip282559103)	2.5M	QoQ NEW(+2.5M) YoY NEW(+2.5M)	All Managers (Combined)	$18.2M	3.2% ($18.2M/$562.5M)	QoQ NEW(+$18.2M) YoY NEW(+$18.2M)
SOLENO THERAPEUTICS INC(SLNOcusip834203309)	250.0K	QoQ -28.57% (-100.0K) YoY NEW(+250.0K)	All Managers (Combined)	$17.9M	3.2% ($17.9M/$562.5M)	QoQ +13.53% (-$2.1M) YoY NEW(+$17.9M)
Erasca, Inc.(ERAScusip29479A108)	13.0M	QoQ +4.00% (-500.0K) YoY NEW(+13.0M)	All Managers (Combined)	$17.8M	3.2% ($17.8M/$562.5M)	QoQ -43.23% (-$13.6M) YoY NEW(+$17.8M)
OCULAR THERAPEUTIX, INC(OCULcusip67576A100)	2.3M	QoQ -34.28% (-1.2M) YoY -60.42% (-3.5M)	All Managers (Combined)	$16.9M	3.0% ($16.9M/$562.5M)	QoQ -43.59% (-$13.0M) YoY -67.57% (-$35.1M)
Design Therapeutics, Inc.(DSGNcusip25056L103)	4.2M	QoQ 0.00% (-0) YoY -16.19% (-814.9K)	All Managers (Combined)	$16.3M	2.9% ($16.3M/$562.5M)	QoQ -37.43% (-$9.7M) YoY -19.72% (-$4.0M)
MoonLake Immunotherapeutics(MLTXcusip61559X104)	350.0K	QoQ NEW(+350.0K) YoY NEW(+350.0K)	All Managers (Combined)	$13.7M	2.4% ($13.7M/$562.5M)	QoQ NEW(+$13.7M) YoY NEW(+$13.7M)
GERON CORP(GERNcusip374163103)	8.0M	QoQ +300.00% (+6.0M) YoY -11.11% (-1.0M)	All Managers (Combined)	$12.7M	2.3% ($12.7M/$562.5M)	QoQ +79.66% (+$5.6M) YoY -57.17% (-$17.0M)
Olema Pharmaceuticals, Inc.(OLMAcusip68062P106)	3.2M	QoQ 0.00% (-0) YoY -26.80% (-1.2M)	All Managers (Combined)	$12.1M	2.1% ($12.1M/$562.5M)	QoQ -35.50% (-$6.6M) YoY -75.68% (-$37.6M)
Crinetics Pharmaceuticals, Inc.(CRNXcusip22663K107)	350.0K	QoQ NEW(+350.0K) YoY NEW(+350.0K)	All Managers (Combined)	$11.7M	2.1% ($11.7M/$562.5M)	QoQ NEW(+$11.7M) YoY NEW(+$11.7M)
Avidity Biosciences, Inc.(RNAcusip05370A108)	350.0K	QoQ NEW(+350.0K) YoY NEW(+350.0K)	All Managers (Combined)	$10.3M	1.8% ($10.3M/$562.5M)	QoQ NEW(+$10.3M) YoY NEW(+$10.3M)